Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Relapse”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07409428
What this trial is testing

A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL

Who this might be right for
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Hutchmed 240
Testing effectiveness (Phase 2)Ended earlyNCT00479167
What this trial is testing

A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Follicular Lymphoma
Rush University Medical Center 1
Testing effectiveness (Phase 2)Study completedNCT03697629
What this trial is testing

An Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in Relapse
Canadian Myeloma Research Group 40
Testing effectiveness (Phase 2)Study completedNCT01533181
What this trial is testing

Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Carcinoma
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)UnknownNCT05875428
What this trial is testing

Mitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-Cell Lymphoma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 104
Testing effectiveness (Phase 2)Looking for participantsNCT06607692
What this trial is testing

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Who this might be right for
Solid Tumor CancerMedulloblastomaHigh Risk Neuroblastoma+19 more
Fundación de investigación HM 25
Testing effectiveness (Phase 2)Looking for participantsNCT05868395
What this trial is testing

Efficacy of Polatuzumab, Bendamustine and Rituximab in Patients With Relapsed/ Refractory Mantle Cell Lymphoma

Who this might be right for
Mantle-cell Lymphoma
Medical University of Vienna 16
Testing effectiveness (Phase 2)Study completedNCT00003957
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Fox Chase Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT02484430
What this trial is testing

Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative+3 more
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Study completedNCT01068392
What this trial is testing

Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)

Who this might be right for
B-cell Lymphomas
Dong-A University Hospital 42
Early research (Phase 1)Ended earlyNCT05289492
What this trial is testing

Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
iTeos Therapeutics 16
Not applicableEnded earlyNCT03777410
What this trial is testing

Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma

Who this might be right for
Multiple Myeloma in Relapse
Travera Inc 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT04124497
What this trial is testing

A Trial for Relapsed and Relapsed/Refractory Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaDeletion 17P Syndrome
Fondazione EMN Italy Onlus 45
Testing effectiveness (Phase 2)Ended earlyNCT00617890
What this trial is testing

Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)

Who this might be right for
OsteosarcomaSarcoma, Ewing'sPeripheral Neuroectodermal Tumor
Merck Sharp & Dohme LLC 219
Not applicableUnknownNCT06205823
What this trial is testing

Compare Clinical Outcomes Between Advanced Immunotherapy and Classical Immunochemotherapy in RRMM

Who this might be right for
Myeloma Multiple
Seoul St. Mary's Hospital 1,600
Early research (Phase 1)Study completedNCT03915379
What this trial is testing

JNJ-67571244 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Janssen Research & Development, LLC 68
Early research (Phase 1)Study completedNCT02222688
What this trial is testing

UC-961 (Cirmtuzumab) in Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Thomas Kipps 26
Testing effectiveness (Phase 2)Looking for participantsNCT05789303
What this trial is testing

Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapse Multiple Myeloma
University of Chicago 83
Early research (Phase 1)Study completedNCT00554827
What this trial is testing

Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

Who this might be right for
Cutaneous T-cell Lymphoma
Acrotech Biopharma Inc. 55
Early research (Phase 1)Looking for participantsNCT04024761
What this trial is testing

Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesMyeloproliferative Neoplasm+1 more
Dana-Farber Cancer Institute 50
Next Page